Bioventus Inc Cash Flow-to-Debt Ratio
Bioventus Inc cash flow-to-debt ratio. Bioventus Inc (BVS) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2026, meaning its operating cash flow of $19.87 Million could theoretically repay 0% of its total liabilities ($395.93 Million) in one year. Check earnings quality score of Bioventus Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Bioventus Inc (2014–2025)
Cash flow-to-debt ratio of Bioventus Inc from 2014 to 2025. Historical debt coverage capacity for Bioventus Inc across 10 annual periods. Check Bioventus Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Bioventus Inc Cash Flow-to-Debt Ratio by Year (2014–2025)
Bioventus Inc cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Bioventus Inc. For the full cash flow conversion analysis, see BVS operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | $73.98 Million | $455.11 Million | ▲ +127.2% |
| 2024 | 0.07x | $38.80 Million | $542.35 Million | ▲ +175.0% |
| 2023 | 0.03x | $15.34 Million | $589.79 Million | ▲ +284.6% |
| 2022 | -0.01x | $-13.54 Million | $960.43 Million | ▼ -142.4% |
| 2021 | 0.03x | $22.99 Million | $692.07 Million | ▼ -83.8% |
| 2020 | 0.20x | $71.80 Million | $350.31 Million | ▲ +64.5% |
| 2019 | 0.12x | $40.71 Million | $326.79 Million | ▼ -18.0% |
| 2018 | 0.15x | $45.19 Million | $297.46 Million | ▲ +136.9% |
| 2015 | 0.06x | $18.92 Million | $295.01 Million | ▲ +7.4% |
| 2014 | 0.06x | $15.11 Million | $252.93 Million | — |